BSECompany Update30 Jul 2026 · 30 Jul 2026, 03:13 pm
As Attached
Eris Lifesciences Ltd · 540596
✦ AI SummaryMgmt Change
Eris Lifesciences Ltd has announced an analyst/institutional investor meeting on August 4, 2026, where the management will discuss publicly available documents and no unpublished price-sensitive information will be shared.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
e686d7ec-6ce9-478b-95ba-6906f00f1c1d.pdf
View document text
Date: 30 July 2026
To To
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza
Dalal Street Bandra Kurla Complex
Mumbai – 400001 Bandra (E)
Mumbai – 400051
Security Code: 540596 Symbol: ERIS
SUBJECT: INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING
Dear Sir/Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we
wish to inform you that the Management of Eris Lifesciences Limited will be participating in the following
Investor Conferences:
Management Mode of
Day and Date Fund Name Meeting Details
Representatives Meeting
Tuesday, 4:00 PM IST,
Bandhan Mutual Mr. Krishnakumar
Virtual
Fund Vaidyanathan
Aug 04, 2026 1X1
The above schedule is indicative and is subject to changes necessitated by any unforeseen developments.
The company will be referring to publicly available documents for discussions during interaction in the meeting
and no unpublished price sensitive information (UPSI) is intended to be discussed during the interaction.
Thanking You,
For Eris Lifesciences Limited
Milind Talegaonkar
Company Secretary & Compliance Officer
Membership No: A26493